At a valuation of just 10 times FCF, Proto Labs stock could be a bargain.
Proto Labs, Inc. (NYSE:PRLB ) Q3 2024 Earnings Conference Call November 1, 2024 8:00 AM ET Company Participants Jason Frankman - VP and Corporate Controller Rob Bodor - President and CEO Dan Schumacher - CFO Conference Call Participants Brian Drab - William Blair Jim Ricchiuti - Needham & Company Troy Jensen - Cantor Fitzgerald Greg Palm - Craig-Hallum Capital Operator Greetings. Welcome to Proto Labs Third Quarter 2024 Earnings Call.
Proto Labs (PRLB) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.51 per share a year ago.
NEW YORK, NY / ACCESSWIRE / October 31, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Proto Labs, Inc. ("Proto Labs") (NYSE:PRLB) concerning possible violations of federal securities laws. On November 4, 2022, Proto reported Q3 results meeting the low end of its prior guidance and then announced lower than expected guidance for Q4 2024.
NEW YORK, NY / ACCESSWIRE / October 30, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Proto Labs, Inc. ("Proto Labs") (NYSE:PRLB) concerning possible violations of federal securities laws. On November 4, 2022, Proto reported Q3 results meeting the low end of its prior guidance and then announced lower than expected guidance for Q4 2024.
NEW YORK, NY / ACCESSWIRE / October 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Proto Labs, Inc. ("Proto Labs") (NYSE:PRLB) concerning possible violations of federal securities laws. On November 4, 2022, Proto reported Q3 results meeting the low end of its prior guidance and then announced lower than expected guidance for Q4 2024.
NEW YORK, NY / ACCESSWIRE / October 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Proto Labs, Inc. ("Proto Labs") (NYSE:PRLB) concerning possible violations of federal securities laws. On November 4, 2022, Proto reported Q3 results meeting the low end of its prior guidance and then announced lower than expected guidance for Q4 2024.
NEW YORK, NY / ACCESSWIRE / October 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Proto Labs, Inc. ("Proto Labs") (NYSE:PRLB) concerning possible violations of federal securities laws. On November 4, 2022, Proto reported Q3 results meeting the low end of its prior guidance and then announced lower than expected guidance for Q4 2024.
NEW YORK, NY / ACCESSWIRE / October 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Proto Labs, Inc. ("Proto Labs") (NYSE:PRLB) concerning possible violations of federal securities laws. On November 4, 2022, Proto reported Q3 results meeting the low end of its prior guidance and then announced lower than expected guidance for Q4 2024.
NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Proto Labs, Inc. ("Proto Labs") (NYSE:PRLB) concerning possible violations of federal securities laws. On November 4, 2022, Proto reported Q3 results meeting the low end of its prior guidance and then announced lower than expected guidance for Q4 2024.
NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Proto Labs, Inc. ("Proto Labs") (NYSE:PRLB) concerning possible violations of federal securities laws. On November 4, 2022, Proto reported Q3 results meeting the low end of its prior guidance and then announced lower than expected guidance for Q4 2024.
NEW YORK, NY / ACCESSWIRE / October 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Proto Labs, Inc. ("Proto Labs") (NYSE:PRLB) concerning possible violations of federal securities laws. On November 4, 2022, Proto reported Q3 results meeting the low end of its prior guidance and then announced lower than expected guidance for Q4 2024.